HOOKIPA Pharma Inc. (HOOK) Reports Promising Anti-Tumor Activity & Favorable Tolerability for Phase 1 Monotherapy Data of HB-201 for Treatment of Advanced HPV16+ Cancers
Go back to HOOKIPA Pharma Inc. (HOOK) Reports Promising Anti-Tumor Activity & Favorable Tolerability for Phase 1 Monotherapy Data of HB-201 for Treatment of Advanced HPV16+ Cancers| Craft Brewers Alliance, Inc. (NASDAQ: HOOK) | Delayed: 0.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $10.17 | |||
| Open | $0.84 | 52 Week Low | $5.08 | |||
| Day High | $0.84 | P/E | 1.65 | |||
| Day Low | $0.84 | EPS | $0.51 | |||
| Volume | 1,001 | |||||
